These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6297671)

  • 1. Recovery of function and basal ganglia [14C]2-deoxyglucose uptake after nigrostriatal injury.
    Kozlowski MR; Marshall JF
    Brain Res; 1983 Jan; 259(2):237-48. PubMed ID: 6297671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of function after mesotelencephalic dopaminergic injury in senescence.
    Marshall JF; Drew MC; Neve KA
    Brain Res; 1983 Jan; 259(2):249-60. PubMed ID: 6297672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Deoxyglucose autoradiographic evidence that fetal substantia nigra grafts exert contralateral effects in 6-hydroxydopamine-lesioned animals who recover motor asymmetries.
    Zainos-Rosales A; Aguilar-Roblero R; Mendoza-Ramírez JL; Drucker-Colín R
    Neurosci Lett; 1993 Jun; 156(1-2):99-104. PubMed ID: 8414199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional (14C) 2-deoxyglucose uptake during vibrissae movements evoked by rat motor cortex stimulation.
    Sharp FR; Evans K
    J Comp Neurol; 1982 Jul; 208(3):255-87. PubMed ID: 7119161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered succinate dehydrogenase activity of basal ganglia following to mesotelencephalic dopaminergic projection.
    Marshall JF; Critchfield JW; Kozlowski MR
    Brain Res; 1981 May; 212(2):367-77. PubMed ID: 7225874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P.
    Dermon CR; Tzagournissakis M; Savaki HE
    Neuroscience; 1992 Oct; 50(4):795-809. PubMed ID: 1280349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activity of substantia nigra grafts reinnervating the striatum: neurotransmitter metabolism and [14C]2-deoxy-D-glucose autoradiography.
    Schmidt RH; Ingvar M; Lindvall O; Stenevi U; Björklund A
    J Neurochem; 1982 Mar; 38(3):737-48. PubMed ID: 6120214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR; Neve KA; Grisham JE; Marshall JF
    Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dopamine-sensitive striatal efferent system mapped with [14C]deoxyglucose in the rat.
    Brown LL; Wolfson LI
    Brain Res; 1983 Feb; 261(2):213-29. PubMed ID: 6831209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in local cerebral glucose utilization during electrical stimulation of the striatum and globus pallidus in rats.
    Aiko Y; Hosokawa S; Shima F; Kato M; Kitamura K
    Brain Res; 1988 Feb; 442(1):43-52. PubMed ID: 3359255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific alterations in local cerebral glucose utilization following striatal lesions.
    Kelly PA; Graham DI; McCulloch J
    Brain Res; 1982 Feb; 233(1):157-72. PubMed ID: 7059797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.
    Herkenham M; Lynn AB; de Costa BR; Richfield EK
    Brain Res; 1991 May; 547(2):267-74. PubMed ID: 1909204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of a pallido-nigral projection innervating dopaminergic neurons.
    Hattori T; Fibiger HC; McGeer PL
    J Comp Neurol; 1975 Aug; 162(4):487-504. PubMed ID: 50334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local cerebral metabolic effects induced by nigral stimulation following ventromedial thalamic lesions. I: Basal ganglia and related motor structures.
    Savaki HE; Girault JA; Desban M; Glowinski J; Besson MJ
    Brain Res Bull; 1984 Jun; 12(6):609-16. PubMed ID: 6383525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical lesions interfere with behavioral recovery from unilateral substantia nigra lesions induced by brain grafts.
    Freed WJ; Cannon-Spoor HE
    Behav Brain Res; 1989 Apr; 32(3):279-88. PubMed ID: 2713080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the dopaminergic nigrostriatal bundle in the pathogenesis of altered brain glucose consumption after lateral hypothalamic lesions. Evidence using the 14C-labeled deoxyglucose technique.
    Schwartz WJ
    Brain Res; 1978 Dec; 158(1):129-47. PubMed ID: 21348356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efferent connections of the caudate nucleus, including cortical projections of the striatum and other basal ganglia: an autoradiographic and horseradish peroxidase investigation in the cat.
    Royce GJ; Laine EJ
    J Comp Neurol; 1984 Jun; 226(1):28-49. PubMed ID: 6736295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.